Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Paclitaxel, Carboplatin|DRUG: Paclitaxel, Epirubicin
Sponsor: Tianjin Medical University Cancer Institute and Hospital